Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal-Reference-Cited by-同舟云学术

Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal

Published:2015-07-25 Issue:1 Volume:16 Page:135-139
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Jones Christopher A,Ducis Katrina,Petrozzino Jeffrey,Clark Eric,Fung Mark K,Peters Christian,Sarkar Indra Neil,Krol Emilia,Pochal Brina,Boutrus Amanda,Weimersheimer Peter,Freeman Kalev

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737167.2015.1071194

Reference18 articles.

1. Outcomes of Urgent Warfarin Reversal With Frozen Plasma Versus Prothrombin Complex Concentrate in the Emergency Department

2. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding

3. Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)

4. Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study

5. Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH);BMC Neurology;2021-03-03

2. Cerebral Hemorrhage and High INR;Neurocritical Care for Neurosurgeons;2021

3. Association of four‐factor prothrombin complex concentrate with subsequent plasma transfusion: A retrospective cohort study;Transfusion Medicine;2020-09-27

4. A Split From Conventional Blood Component Therapy?;Journal of Cardiothoracic and Vascular Anesthesia;2018-02

5. Limitations of traditional health technology assessment methods and implications for the evaluation of novel therapies;Current Medical Research and Opinion;2017-07-31